Medicinal Products

Tuesday, 26 May 2026

Questions (1103, 1127)

Sorca Clarke

Question:

1103. Deputy Sorca Clarke asked the Minister for Health the timeline for a decision by the HSE drugs group regarding the reimbursement of risdiplam for adults living with spinal muscular atrophy. [38725/26]

View answer

Tom Brabazon

Question:

1127. Deputy Tom Brabazon asked the Minister for Health the timeline for a decision by the HSE drugs group regarding the reimbursement of risdiplam for adults living with spinal muscular atrophy. [38838/26]

View answer

Written answers

Minister for Health

I propose to take Questions Nos. 1103 and 1127 together.

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.